Clinical Trial Update: Mercury Chelation to Treat Autism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating mercury chelation for autism sponsored by the National Institute of Mental Health has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Autism, Asperger's Disorder | Phase 2 | Status: WITHDRAWN